REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Jupiter Neurosciences Inc. (United States)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Jupiter Neurosciences Inc. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Jupiter Neurosciences, Inc is a pharmaceutical company. The company has developed a resveratrol product called JOTROL, which is being studied as a potential treatment for Alzheimer's disease and rare diseases. The product is known for reaching therapeutic levels without GI-side effects and has multiple potential disease applications.

Headquarters
1001 North Us Hwy 1, Suite 504
Jupiter; Florida; Postal Code: 33477

Contact Details: Purchase the Jupiter Neurosciences Inc. report to view the information.

Website: http://www.jupiterneurosciences.com

Basic Information
Total Employees:
Purchase the Jupiter Neurosciences Inc. report to view the information.
Outstanding Shares:
Purchase the Jupiter Neurosciences Inc. report to view the information.
Financial Auditors:
Purchase the Jupiter Neurosciences Inc. report to view the information.
Incorporation Date:
March 09, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
38%
Purchase this report to view the information.
11%
Purchase this report to view the information.
10%
Purchase this report to view the information.
6.1%
Purchase this report to view the information.
4.9%
Company Performance
Financial values in the chart are available after Jupiter Neurosciences Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Operating Profit/Loss (EBIT)
-282.93%▼
EBITDA
-273.55%▼
Net Profit/Loss for the Period
-565.57%▼
Total Assets
2895.35%▲
Total Equity
N/A
Return on Equity (ROE)
N/A
Debt/Equity
N/A

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo